Form 4: Centene CEO Sarah London Reports Changes in Beneficial Ownership
SEC Form 4
Centene CEO Sarah London reports acquisition and disposal of company stock, including shares withheld for taxes and vesting of restricted stock units.
Summary
- On March 15, 2025, Centene CEO Sarah London reported changes in her beneficial ownership of Centene Corp stock.
- 20,719 shares were disposed of to cover taxes upon the vesting of previously reported restricted stock units at a price of $58.19 per share.
- She also acquired 261,213 shares of common stock at $0, increasing her total holdings to 826,045 shares.
- This acquisition includes 104,485 restricted stock units vesting in three annual installments and 156,728 performance stock units reported at target level performance.
- London also holds a Common Stock Option (right to buy) at $81.85, which may become exercisable on or after December 15, 2024, if CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into executive stock transactions.
Future Outlook
The vesting of restricted stock units and performance stock units is subject to vesting requirements and performance conditions, respectively.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- Shareholders can monitor insider transactions for insights into management's perspective on the company's value.
- The transactions have a minor impact on the overall shareholding structure.
Key Dates
| Date | Description |
|---|---|
| 12/15/2021 | Date of Performance Stock Option grant |
| 03/15/2025 | Date of transaction (stock disposal and acquisition) |
| 03/18/2025 | Date of signature |
| 12/15/2031 | Expiration date of Common Stock Option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.